Quality of life and economic impact of switching from established infliximab therapy to adalimumab in patients with rheumatoid arthritis

    Research output: Contribution to journalArticlepeer-review

    Original languageEnglish (Ireland)
    Pages (from-to)1148-1152
    JournalRheumatology
    Publication statusPublished - 2007

    Cite this